Literature DB >> 17116180

Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.

C Hu1, W Jia, Q Fang, R Zhang, C Wang, J Lu, K Xiang.   

Abstract

AIMS: Previous studies have shown that the peroxisome proliferator-activated receptor delta (PPARD) genetic polymorphism affects cholesterol metabolism in Whites. This association was not observed in a Korean population in a separate study, but this study showed a link between the PPARD polymorphism and body weight and fasting plasma glucose. The purpose of this study was to determine whether polymorphisms of PPARD influence glucose and cholesterol metabolism in Chinese subjects. We investigated the association between the polymorphism (-87T/C) of the human PPARD gene and phenotypes related to body weight, insulin sensitivity, glucose and lipid metabolism in Chinese subjects.
METHODS: Unrelated Chinese subjects (n = 663) in Shanghai were studied; 287 had newly diagnosed Type 2 diabetes mellitus and 376 were non-diabetic control subjects over 40 years old. Clinical parameters were collected and genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: In normal glucose tolerant (NGT) subjects, the C allele carriers had higher fasting plasma glucose concentrations (P = 0.0078) and a lower insulin sensitivity index (ISI) (P = 0.0365). The C allele carriers also showed higher concentrations of low-density lipoprotein cholesterol (P = 0.0261) and percentage of body fat (P = 0.0357). There was a trend towards higher visceral adiposity in C allele carriers, but the difference was not significant (P = 0.0830). In diabetes patients, similar results were detected for plasma glucose concentrations (fasting plasma glucose P < 0.0001, 2-h plasma glucose P = 0.0052) and insulin sensitivity (homeostasis model assessment of insulin resistance P = 0.0094; ISI P = 0.0058).
CONCLUSION: The PPARD-87T/C polymorphism is associated with higher fasting plasma glucose concentrations in both NGT and diabetic subjects, largely due to impaired insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116180     DOI: 10.1111/j.1464-5491.2006.02001.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  15 in total

1.  Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.

Authors:  Raquel Villegas; Scott Williams; Yutang Gao; Qiuyin Cai; Honglan Li; Tom Elasy; Hui Cai; Todd Edwards; Yong-Bing Xiang; Wei Zheng; Jirong Long; Xiao Ou Shu
Journal:  Ann Hum Genet       Date:  2011-09       Impact factor: 1.670

Review 2.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

Review 3.  Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.

Authors:  Chen Dong; Hui Zhou; Chong Shen; Lu-Gang Yu; Yi Ding; Yong-Hong Zhang; Zhi-Rong Guo
Journal:  World J Diabetes       Date:  2015-05-15

4.  Regulation of skeletal muscle PPAR delta mRNA expression in twins.

Authors:  Emma Nilsson; Pernille Poulsen; Marketa Sjögren; Charlotte Ling; Martin Ridderstråle; Leif Groop; Allan Vaag
Journal:  J Physiol       Date:  2007-09-13       Impact factor: 5.182

5.  Effect of genetic polymorphism +294T/C in peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in a Tunisian population.

Authors:  Khouloud Chehaibi; Mohamed Yahia Hrira; Mustapha Rouis; Mohamed Najah; Imen Jguirim-Souissi; Samir Nouira; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2013-03-20       Impact factor: 3.444

6.  Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes.

Authors:  Raquel Villegas; Scott M Williams; Yu-Tang Gao; Jirong Long; Jiajun Shi; Hui Cai; Honglan Li; Ching-Chu Chen; E Shyong Tai; Frank Hu; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu
Journal:  Ann Hum Genet       Date:  2014-01       Impact factor: 1.670

7.  Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly Chinese.

Authors:  Ling Lu; Ying Wu; Qibin Qi; Chen Liu; Wei Gan; Jingwen Zhu; Huaixing Li; Xu Lin
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 8.  Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.

Authors:  Greta M P Giordano Attianese; Béatrice Desvergne
Journal:  Nucl Recept Signal       Date:  2015-04-27

9.  Mixed modeling of meta-analysis P-values (MixMAP) suggests multiple novel gene loci for low density lipoprotein cholesterol.

Authors:  Andrea S Foulkes; Gregory J Matthews; Ujjwal Das; Jane F Ferguson; Rongheng Lin; Muredach P Reilly
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China.

Authors:  Shih-Chen Chang; Asif Rashid; Yu-Tang Gao; Gabriella Andreotti; Ming-Chang Shen; Bin-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Lori C Sakoda; Michael F Leitzmann; Bingshu E Chen; Philip S Rosenberg; Jinbo Chen; Stephen J Chanock; Ann W Hsing
Journal:  Carcinogenesis       Date:  2008-03-28       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.